BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Massachusetts’ Haemonetics to Eliminate 350 Jobs

  Shares of Haemonetics are up nearly 10 percent this morning after the company announced it was cutting about 11 percent of its workforce in a restructuring effort.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Blackstone to Sell Stake in Xinrong Best Medical, Deal Could Fetch $400M

  The PE firm made the investment just three years ago.

  November 7, 2017

   · 

  1 min read
• 

  San Diego Biotech Progenity Banks $125M for Precision Medicine R&D

  Progenity snagged $125M in funding that will allow the company to accelerate development of its gastrointestinal platform.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Senator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug

  Harris fired the first shots on Monday.

  November 7, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Beach

  Puma Biotech Locks in $100M Loan to Market Newly-Approved Breast Cancer Drug

  Puma received gross proceeds of $50 million from the first tranche of the credit facility upon closing on Oct. 31.

  November 7, 2017

   · 

  1 min read
• 

  Drug Development

  Confident Bristol-Myers to Launch 700-Patient Phase III IDO Trial for Melanoma

  Bristol-Myers is initiating a Phase III clinical trial of BMS-986205 with nivolumab in patients with advanced melanoma.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Boston Scientific Recalls Certain Sizes of Eluvia, Innova Stents

  The company is pulling these particular devices due to the number of complaints that it received relating to partial stent deployment.

  November 7, 2017

   · 

  1 min read
• 

  Deals

  Cantrell Drug Company Files for Chapter 11 Bankruptcy

  Nearly four months after issuing a voluntary recall of all lots of unexpired sterile drug products, Cantrell Drug Company has filed for bankruptcy.

  November 7, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Of 3,500 Eli Lilly Worldwide Job Cuts, 2,300 in U.S. Took Voluntary Severance

  The cuts were expected to save the company $500M.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Takeda, Portal Instruments Ink $100M Deal to Develop Needle-Free Drug Delivery Device

  Takeda inked a collaboration deal to develop and commercialize Portal’s needle-free drug delivery device for use with some of Takeda’s biologic medicines.

  November 7, 2017

   · 

  2 min read

   · 

  Mark Terry